| Researchers found that a combination treatment with arthritis drugs methotrexate and sulfasalazine was no more beneficial to patients with early rheumatoid arthritis than either drug administered alone.
The combined therapy, given during the first year of disease onset, did not influence inflammation, disability or structural changes in the long term.
Annals of the Rheumatic Diseases August, 2003
|